Topic Hub
11 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 11 of 11 clinical reviews.
A physician-reviewed guide to the 5-HTP and Rezdiffra (resmetirom) interaction: mechanism, serotonin syndrome risk, pharmacokinetics, monitoring, and safe-use guidance for patients with MASH.
Read clinical reviewA clinical review of the pharmacokinetic and pharmacodynamic interactions between berberine and resmetirom (Rezdiffra) for patients managing MASH, including monitoring guidance and dose considerations.
Read clinical reviewA physician-reviewed guide to calcium and resmetirom (Rezdiffra) interactions, covering pharmacokinetics, dose-separation windows, monitoring parameters, and safety evidence for MASH patients.
Read clinical reviewEvidence-based guide to combining CoQ10 supplements with Rezdiffra (resmetirom) for MASH. Covers interaction risk, pharmacokinetics, dose-separation strategy, and monitoring.
Read clinical reviewA clinical review of the ginseng-resmetirom interaction: pharmacokinetic and pharmacodynamic risks, glucose monitoring, anticoagulant concerns, and what to do if you are already taking both.
Read clinical reviewEvidence-based guide on combining glycine supplements with Rezdiffra (resmetirom) for MASH. Covers pharmacokinetic interactions, dose-separation, monitoring, and safety data.
Read clinical reviewEvidence-based guide on combining NAC supplements with Rezdiffra (resmetirom) for MASH. Covers drug-supplement interactions, pharmacokinetics, dosing windows, and monitoring recommendations.
Read clinical reviewEvidence-based guide on combining omega-3 fish oil (EPA/DHA) with Rezdiffra (resmetirom) for MASH. Covers drug-supplement interactions, monitoring, dose separation, and clinical trial data.
Read clinical reviewA clinician-reviewed guide to the pharmacokinetic and pharmacodynamic interaction between quercetin and resmetirom (Rezdiffra), with dosing guidance, monitoring parameters, and safety considerations for MASH patients.
Read clinical reviewResveratrol may inhibit CYP3A4 and alter resmetirom exposure. Learn about the pharmacokinetic interaction, dose-separation strategies, monitoring recommendations, and what to tell your prescriber if you already take both.
Read clinical reviewEvidence-based guide to taking turmeric or curcumin supplements alongside Rezdiffra (resmetirom) for MASH, including interaction risks, dose-separation strategies, and monitoring recommendations.
Read clinical review